The results showed that IGFBP-1 also showed high diagnostic efficacy in CEA/CA19-9 negative CRC, and similar results were also obtained in CEA/CA19-9 negative early CRC, as shown in Table 2. The gene discussed is CEACAM5; the disease is colorectal carcinoma.